Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.58), $0.60 better than the analyst estimate of ($1.18).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.